TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Skandinavisk BioTech AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
505
|
570 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
69
|
90 | |
| EBITDA |
61
|
89 | |
| Total assets |
812
|
821 | |
| Current assets |
604
|
614 | |
| Current liabilities |
85
|
85 | |
| Equity capital |
670
|
683 | |
| - share capital |
8
|
9 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
82.5%
|
83.2% | |
| Turnover per employee |
505
|
570 | |
| Profit as a percentage of turnover |
13.7%
|
15.8% | |
| Return on assets (ROA) |
8.5%
|
11.0% | |
| Current ratio |
710.6%
|
722.4% | |
| Return on equity (ROE) |
10.3%
|
13.2% | |
| Change turnover |
-9
|
194 | |
| Change turnover % |
-2%
|
-2%
|
52% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.